In fiscal year 2025, BioNote (377740) reported revenue of 118.3 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 118.3 billion KRW | 16.7 billion KRW | -87.5 billion KRW | [source] |
| 2024 | 102.8 billion KRW | 12.2 billion KRW | 55.3 billion KRW | [source] |
| 2023 | 90.1 billion KRW | -47.0 billion KRW | -20.5 billion KRW | [source] |
| 2022 | 479.7 billion KRW | 295.4 billion KRW | 307.8 billion KRW | [source] |
| 2021 | 622.4 billion KRW | 468.7 billion KRW | 676.6 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 1.07 trillion KRW | 13.6 billion KRW | 1.05 trillion KRW | [source] |
| 2024 | 1.08 trillion KRW | 25.5 billion KRW | 1.05 trillion KRW | [source] |
| 2023 | 1.00 trillion KRW | 12.6 billion KRW | 989.0 billion KRW | [source] |
| 2022 | 1.10 trillion KRW | 49.6 billion KRW | 1.05 trillion KRW | [source] |
| 2021 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.